Affimed Announces Addition of Dr. Constanze Ulmer-Eilfort to its Supervisory Board
HEIDELBERG, Germany, June 22, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company...
Year: 2023
MannKind Launches Inhale-3 Study to Address the Most Important Unmet Need Today in Adults Living With Type 1 Diabetes (T1D)
Large trial in adults comparing A1c and mealtime control when switching from injectable insulin or pumps to inhaled insulin (Afrezza®...
Reviva Pharmaceuticals Announces 80% Global Enrollment Update for Pivotal Phase 3 RECOVER Study Evaluating Brilaroxazine for Schizophrenia
- Enrollment ongoing at multiple sites in the US, Europe, and Asia - - Multifaceted activity of serotonin-dopamine stabilizer brilaroxazine...
Immuron Business Update: Letter to Shareholders
Highlights: Immuron Board approves IMM-529 cGMP manufacturing and to proceed with FDA pre-IND submissionRecruitment and screening update for Travelan® Controlled...
Sai Life Sciences joins Science Based Targets initiative (SBTi), commits to fight climate change with Science
Sai Life Sciences joins SBTi Sai Life Sciences joins SBTi HYDERABAD, India, June 22, 2023 (GLOBE NEWSWIRE) -- To help...
Madrigal Pharmaceuticals Presents Phase 3 MAESTRO-NASH Data During the Opening General Session of the EASL Congress™
First scientific presentation of detailed MAESTRO-NASH results confirms achievement of primary endpoints across multiple patient subgroupsNoninvasive imaging and biomarker data...
TELUS Mental Health Index revealed workplace collaboration linked to positive employee mental health
Mental health score of workers who report lack of employer support sits 10 points below the national averageCHICAGO, June 22,...
TELUS Mental Health Index reveals workplace collaboration is positively linked to employee mental health
Despite 25 per cent of managers reporting team conflict, mental health of workers remains unchanged levelling with earliest stages of...
Long-time Collaborators Botond Roska and José-Alain Sahel Win International Prize for Translational Neuroscience
J-A. Sahel (left)_B.Roska (right) J-A. Sahel (left)_B.Roska (right)Basel, Switzerland, June 22, 2023 --In recognition of their pioneering work on restoring...
Genomic Vision conclut un accord de distribution avec CliniSciences
GENOMIQUE | THERAPIES CELLULAIRES ET GENIQUES | BIOPRODUCTION Genomic Vision conclut un accord de distribution avec CliniSciences Un accord...
Amarin Announces Vascepa® (Icosapent Ethyl) Approved to Reduce Cardiovascular Risk in the Kingdom of Saudi Arabia (KSA)
-- VASCEPA® Approved in KSA To Reduce the Risk of Cardiovascular (CV) Events as an Adjunct to Statin Therapy in...
Appointment of Dr. Christopher von Jako as new CEO
Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the...
Lumos to Highlight New LUM-201 Data and Analysis Presented at ENDO 2023 in Virtual KOL Webinar
Webinar to Review Data Demonstrating Potential Drug Effect and Durable Response Webinar to be held Today June 21, 2023 at...
VLN® Products Launch in Nevada to Help Smokers Smoke Less
Terrible Herbst and Speedee Mart Selling VLN® Reduced Nicotine Products in Approximately 200 Las Vegas Area Stores FDA Authorized VLN®...
SciSparc Announces IRB Approval to Conduct its Phase IIb Trial in Tourette Syndrome
Company reaches another clinical trial milestone for treatment of Tourette’s with its novel SCI-110 therapy in the United States TEL...
Smart for Life Releases Corporate Video on Roger Conley Wood
Video Represents Latest in the Company’s “Director’s Forum” Series – Observations from the Company’s Independent DirectorsMIAMI, June 21, 2023 (GLOBE...
Eloxx Pharmaceuticals Highlights Recent Alport Syndrome Natural History Data Presented at 60th ERA Congress
Data from RaDaR natural history study indicates that Alport syndrome patients with autosomal recessive COL4A4 mutations have severest disease, with...
Earth Science Tech, Inc Shares a Letter from the CEO on Recently Filed March 31, 2023, YE Report
“You don’t have to be great to start, but you do have to start to be great!” Miami, FL, June...
Dyadic Announced an MoU with Bangladesh’s State-Owned Pharmaceutical Company to Facilitate Biopharmaceutical Research and Biomanufacturing Capacity
JUPITER, Fla. and DHAKA, Bangladesh, June 21, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the...
HMNC Brain Health to Participate in the Psychedelic Science Conference 2023 and the H.C. Wainwright & Co. 4th Annual Neuropsychiatry Conference
MUNICH, Germany, June 21, 2023 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC” or the “company”), a global clinical-stage biopharmaceutical company,...